These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors. Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243 [TBL] [Abstract][Full Text] [Related]
10. Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors. Overcast WB; Davis KM; Ho CY; Hutchins GD; Green MA; Graner BD; Veronesi MC Curr Oncol Rep; 2021 Feb; 23(3):34. PubMed ID: 33599882 [TBL] [Abstract][Full Text] [Related]
11. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience. Henriksen OM; Larsen VA; Muhic A; Hansen AE; Larsson HBW; Poulsen HS; Law I Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):103-112. PubMed ID: 26363903 [TBL] [Abstract][Full Text] [Related]
14. Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[ Langen KJ; Stoffels G; Filss C; Heinzel A; Stegmayr C; Lohmann P; Willuweit A; Neumaier B; Mottaghy FM; Galldiks N Methods; 2017 Nov; 130():124-134. PubMed ID: 28552264 [TBL] [Abstract][Full Text] [Related]
15. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561 [TBL] [Abstract][Full Text] [Related]
16. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081 [TBL] [Abstract][Full Text] [Related]
17. From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors? Galldiks N; Langen KJ; Pope WB Neuro Oncol; 2015 Nov; 17(11):1434-44. PubMed ID: 26130743 [TBL] [Abstract][Full Text] [Related]
18. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas? Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients. Lapa C; Linsenmann T; Monoranu CM; Samnick S; Buck AK; Bluemel C; Czernin J; Kessler AF; Homola GA; Ernestus RI; Löhr M; Herrmann K J Nucl Med; 2014 Oct; 55(10):1611-6. PubMed ID: 25125481 [TBL] [Abstract][Full Text] [Related]
20. The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy. Galldiks N; Law I; Pope WB; Arbizu J; Langen KJ Neuroimage Clin; 2017; 13():386-394. PubMed ID: 28116231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]